volume 18 • number 1 • february 2018 - immune network · 2018. 3. 5. · dulshara sachini...
TRANSCRIPT
-
pISSN 1598-2629eISSN 2092-6685
Volume 18 • Number 1 • February 2018
https://immunenetwork.org
“Open Access, Peer-reviewed”
The Korean Association of Immunologists
Volume 18 • N
umber 1 • February 2018
The Korean Association of Imm
unologists
-
immunenetwork.org
Control of Innate and Adaptive Lymphocytes by the RAR-Retinoic Acid AxisChang H. Kim in.2018.18.e1
Tissue-specific Role of CX3CR1 Expressing Immune Cells and Their Relationships with Human DiseaseMyoungsoo Lee, Yongsung Lee, Jihye Song, Junhyung Lee, Sun-Young Chang in.2018.18.e5
Regulation of Cellular Antiviral Signaling by Modifications of Ubiquitin and Ubiquitin-like MoleculesKang Li, Bo Zhong in.2018.18.e4
The Role of Reactive Oxygen Species in Regulating T Cell-mediated Immunity and DiseaseEmily L. Yarosz, Cheong-Hee Chang in.2018.18.e14
Regulation of Osteoclast Differentiation by Cytokine Networks Dulshara Sachini Amarasekara, Hyeongseok Yun, Sumi Kim, Nari Lee, Hyunjong Kim, Jaerang Rho in.2018.18.e8
Out-sourcing for Trans-presentation: Assessing T Cell Intrinsic and Extrinsic IL-15 Expression with Il15 Gene Reporter MiceJoo-Young Park, Davinna L. Ligons, Jung-Hyun Park in.2018.18.e13
Beyond the Role of CD55 as a Complement Component So Hee Dho, Jae Cheong Lim, Lark Kyun Kim in.2018.18.e11
Regulation of Allergic Immune Responses by Microbial MetabolitesHyun Jung Park, Sung Won Lee, Seokmann Hong in.2018.18.e15
Ectopically Expressed Membrane-bound Form of IL-9 Exerts Immune-stimulatory Effect on CT26 Colon Carcinoma Cells Van Anh Do Thi, Sang Min Park, Hayyoung Lee, Young Sang Kim in.2018.18.e12
Toll-like Receptor 1/2 Agonist Pam3CSK4 Suppresses Lipopolysaccharide-driven IgG1 Production while Enhancing IgG2a Production by B CellsSang-Hoon Lee, Seok-Rae Park in.2018.18.e10
ContentsReview Articles
Original Articles
Copyright © 2018 The Korean Association of Immunologists
Volume 18 • Number 1 • February 2018 | pISSN 1598-2629 • eISSN 2092-6685
https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e1https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e1https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e1https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e5https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e5https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e5https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e4https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e4https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e4https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e14https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e14https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e14https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e8https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e8https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e8https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e13https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e13https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e13https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e13https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e11https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e11https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e11https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e15https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e15https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e15https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e12https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e12https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e12https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e12https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e10https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e10https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e10https://immunenetwork.org/DOIx.php?id=10.4110/in.2018.18.e10